Similarly, a conference abstract in breast cancer survivors described that a 16-week therapeutic yoga program was associated with post-intervention differences in VEGF-A (+45.51%) and MCP-1 (−19.79%) (62). This evidence concerns the gene CCL2 and breast cancer.